Browse > Article

Analysis of Squalene Synthase Expression During the Development of Ganoderma lucidum  

Zhao, M.W. (Microbiology Department, Nanjing Agricultural University, Key Laboratory of Microbiological Engineering of Agricultural Environment, Ministry of Agriculture)
Zhong, J.Y. (Microbiology Department, Nanjing Agricultural University, Key Laboratory of Microbiological Engineering of Agricultural Environment, Ministry of Agriculture)
Liang, W.Q. (Agro-Biotech Research Center, Agricultural Academy of Shanghai, Key Laboratory of Agriculture Genetics and Breeding of Shanghai)
Wang, N. (Agricultural Academy of Shanghai, Key Laboratory of Edible Fungus Genetics and Breeding Edible Fungi Institute, Ministry of Agriculture, Key Laboratory of Agriculture Genetics and Breeding of Shanghai)
Chen, M.J. (Agricultural Academy of Shanghai, Key Laboratory of Edible Fungus Genetics and Breeding Edible Fungi Institute, Ministry of Agriculture, Key Laboratory of Agriculture Genetics and Breeding of Shanghai)
Zhang, D.B. (Agro-Biotech Research Center, Agricultural Academy of Shanghai, Key Laboratory of Agriculture Genetics and Breeding of Shanghai)
Pan, Y.J. (Agricultural Academy of Shanghai, Key Laboratory of Edible Fungus Genetics and Breeding Edible Fungi Institute, Ministry of Agriculture, Key Laboratory of Agriculture Genetics and Breeding of Shanghai)
Jong.S.C. (American Type Culture Collection, 10801 University Boulevard)
Publication Information
Journal of Microbiology and Biotechnology / v.14, no.1, 2004 , pp. 116-120 More about this Journal
Abstract
The medicinal properties of Ganoderma lucidum have been recognized in China for many centuries. Active pharmaceutical components include triterpenes. To elucidate the molecular regulation of triterpene biosynthesis in this mushroom, a 57-base pair DNA fragment encoding the fourth conserved domain SQ-4 (SMGLFLQKTNIIRDYNEDL) of squalene synthase was synthesized and cloned into the expression vector pET-32a(＋). The recombinant fusion protein induced by IPTG (isopropyl-$\beta$-D-thiogalactopyranoside) was overexpressed in the Escherichia coli. Using the purified recombinant fusion protein of 20.9 kDa, a specific polyclonal antibody was obtained from immunized rabbit. Expression of squalene synthase at different development stages of Ganoderma lucidum was analyzed.
Keywords
Expression characteristics; Ganoderma lucidum; squalene synthase; triterpene;
Citations & Related Records

Times Cited By Web Of Science : 11  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Hirotani, M., I. Asaka, and T. Furuya. 1990. Investigation of the biosynthesis of 3-hydroxy triterpenoids, ganoderic acids T and S by application of a feeding experiment using [1,2-$^{13}C_2$]acetate. J. Chem. Soc. Perkin Trans. 1: 2751-2754.
2 Huang, Y. H., W. Q. Liang, A. H. Pan, A. F. Wang, C. Huang, Z. J. Zhao, J. X. Cheng, Z. A. Zhou, and D. B. Zhang. 2001. Cloning and expression of the K99 fimbrial antigen gene of enterotoxigenic Escherichia coli. Chinese Journal of Veterinary Science (in Chinese) 9: 471-474
3 Kohda, H., W. Tokumoto, K. Sakamoto, M. Fujii, Y. Hirai, K. Yamasaki, et al. 1985. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. histamine releaseinhibitory triterpenes. Chem. Pharm. Bull. 33: 1367-1374
4 Hirotani, M. and T. Furuya. 1990. Changes of the triterpenoid patterns during formation of the fruit body in Ganoderma lucidum. Phytochemistry 29: 3767-3771
5 Wang, F. S., H. Cai, J. S. Yang, Y. M. Zhang, C. Y. Hou, J. Q. Liu, and Y. J. Zhao. 1997. Studies on ganoderic acid, a new constituent from the fruiting body of Ganoderma lucidum. Acta Pharmaceutica Sinica (in Chinese) 32: 447-450
6 Komoda, Y., M. Shimizu, Y. Sonoda, and Y. Sato. 1989. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem. Pharm. Bull. 37: 531-973
7 Son, K. H., B. M. Kim, T. Y. Lee, S. R. Kim, K. S. Kim. 1999. Expression and characterization of human T-Cell leukemia virus type-I Env and Gag proteins. J. Microbiol. Biotechnol. 9: 311-317
8 Hanley, K. and J. Chappell. 1992. Solubilization, partial purification, and immunodetection of squalene synthatase from tobacco cell suspension cultures. Plant Physiol. 98: 215-220
9 Sonoda, Y., Y. Sekigawa, and Y. Sato. 1988. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol. Chem. Pharm. Bull. 36: 966-973
10 Takayuki, N., I. Takayuki, O. Atsuhipo, N. Tokuzo, O. Takashi, and H. Shingo. 1995. Cloning, expression, and characterization of cDNAs encoding Arabidopsis thaliana squalene synthase. Proc. Natl. Acad. Sci. USA 92: 2328- 2332
11 Mekkawy, S. EL., M. R. Mesethy, N. N. Mura, Y. Tezuka, M. Hattori, N. Kakiuchi, K. Shimotohno, T. Kawahata. 1998. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49: 1651-1657
12 Cai, H., F. S. Wang, J. S. Yang, Y. M. Zhang, K. Hu, Y. J. Zhao. 1997. Studies on the triterpenoid constituents from the fruiting body of G. lucidum. Chinese Journal of Veterinary Science (in Chinese) 17: 511-513
13 Chang, H. C. and J. W. Kwak. 1997. Periplasmic expression of a recombinant antibody (MabB9) in Escherichia coli. J. Microbiol. Biotechnol. 7: 299-304
14 Min, B. S., N. Nakamura, H. Miyashiro, K. W. Bao, and M. Hattor. 1998. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 46: 1607-1612
15 Zhang, D. L., S. M. Jennings, G. W. Robinson, and D. Poulter. 1993. Yeast squalene synthase: Expression, purification, and characterization of soluble recombinant enzyme. Arch. Biochem. Biophys. 304: 133-143
16 Lin, C. N., W. P. Tome, and S. J. Won. 1991. Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod. 54: 998-1002
17 Lin, Z. B. 1979. The current pharmacological research on Ganoderma lucidum in China. Acta Pharmaceutica Sinica (in Chinese) 14: 183-192
18 Jiang, G. J., T. L. Mckenzie, D. G. Conrad, and I. Shechter. 1993. Transcriptional regulation by lovastatin and 25- hydroxycholesterol in Hepg2 cells and molecular cloningand expression of the cDNA for the human hepatic squalene synthase. J. Biol. Chem. 268: 12818-12824
19 Zhong, J. Y. 2001. Cloning of the squalene synthase gene from Ganoderma lucidum and preliminary analysis of gene expression. Masters Thesis, Nanjing Agricultural University, China
20 Guo, C. Y. 1998. Review of pharmacological research of Ganoderma lucidum. Edible Fungi of China (in Chinese) 17: 34-35
21 Cheng, R. Y. and D. Q. Yu. 1990. Research progress on the chemical component of Ganoderma lucidum triterpenoid. Acta Pharmaceutica Sinica (in Chinese) 25: 940-953
22 Morigiwa, A., K. Kitabatake, Y. Fujimoto, and N. Ikekawa. 1986. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem. Pharm. Bull. 34: 3025- 3028
23 Jennings, S. M., Y. H. Tsay, T. M. Fisch, and G. W. Robinson. 1991. Molecular cloning and characterization of the yeast gene for squalene synthatase. Proc. Natl. Acad. Sci. USA 88: 6038-6042
24 Takayuki, I., O. Takashi, and H. Shingo. 1995. Molecular cloning and functional expression of a cDNA for mouse squalene synthase. Biochim. Biophys. Acta 1260: 49-54
25 Jolidon, S., A. M. Polak, P. Guerry, and P. G. Hartman. 1990. Inhibitors of 2,3-oxidosqualene lanosterol-cyclase as potential antifungal agent. Biochem. Soc. Trans. 18: 47-48
26 Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring harbor, U.S.A